We have characterized HLA incompatibilities in a group of 17 B35-posit
ive patients who were ABDR matched (AB serology and oligotyping for DR
1-14) with their 28 (unrelated) potential bone marrow donors. High-res
olution oligotyping for DR subtypes disclosed that nine combinations w
ere in fact DR mismatched. Cytotoxic T-lymphocyte (CTL) activity was d
etected in nine combinations (32%). In the group matched for DR subtyp
es, three (16%) of 13 combinations were CTL positive. Patient-specific
cytotoxic activity appeared to be directed against HLA C (two cases)
or against a subtype of B35. In the group of DR-subtype-mismatched com
binations, CTL activity was found in six (67%) of nine pairs. In all f
our cases chat were studied in detail, however, CTL reactivity appeare
d to be directed against a variant subtype of B35. We have studied the
B35 incompatibilities recognized in five different combinations by sp
ecificity analysis of the B35-specific CTLs and by partially sequencin
g of relevant segments of B35 exon 3. Preliminary data show that, with
in this relatively small Caucasoid group, at least five B35-variant su
btypes could be distinguished. This would make B35 an antigen that wil
l be frequently subtype mismatched, in particular when DR matching is
done with low resolution (DR1-14) only.